Contacter le RP

Pour utiliser cette fonctionnalité, vous devez bénéficier d'un compte Babbler.


Babbler permet aux journalistes et communicants de collaborer plus simplement.

En vous connectant, vous pourrez accéder gratuitement aux espaces presse des centaines d'entreprises de vos secteurs qui sont sur Babbler, entrer en contact direct avec leurs équipes RP mais aussi y partager vos prochains sujets !

Leurs espaces presse sont sur Babbler :

Vous êtes à 1 clic de l'inscription !


Content de vous revoir !


Migraine Drugs Market Report 2022-2027, Industry Growth, Size, Share, Trends And Forecast
timer minutes de lecture minute de lecture

Copier le lien

Cliquez sur l'image pour obtenir le format original

According to the latest report by IMARC Group, titled “ Migraine Drugs Market Share : Global Industry Trends, Growth, Opportunity and Forecast 2022-2027” , The global migraine drugs market is expected to exhibit a CAGR of XX% during 2022-2027

Migraine represents the neurological condition that causes unilateral or throbbing pain in the side of the head, forehead, and around the eyes. It is usually accompanied by autonomic symptoms, such as vomiting, nausea, photophobia, phonophobia, etc. Migraine is diagnosed by examining the medical history and symptoms of the patient and performing magnetic resonance imaging (MRI), blood tests, computerized tomography (CT) scans, etc. Presently, prescribed injections and over-the-counter (OTC) medicines are widely utilized to minimize the frequency as well as the severity of migraine attacks. They are either taken regularly or during exacerbations of chronic pain.

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the global industry behaviors of the consumers globally. Our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Global Migraine Drugs Market Trends:

The escalating demand for precision medicines is primarily driving the migraine drugs market. Additionally, the rising healthcare expenditure capacities of individuals and extensive improvement in reimbursement policies for migraine medications are further catalyzing the market growth. Besides this, various types of migraine drugs, including ergot alkaloids, triptans, NSAIDs, acetylcholine inhibitors/ neurotoxins, ditans, CGRP mAbs, etc., are commonly available via hospital-based pharmacies, which is acting as another significant growth-inducing factor. Moreover, the development of product variants with novel mechanisms of action or new therapeutic targets and the inflating need for electrical nerve stimulating devices to treat migraine are also positively influencing the global market. In line with this,

Request Free Sample Report:

Global Migraine Drugs Market 2021-2026 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Abbott Laboratories, Allergan Plc (Abbvie Inc.), Amgen Inc., AstraZeneca Plc, Bausch Health Companies Inc. (formerly Valeant Pharmaceuticals), Eisai Co. Ltd., Eli Lilly and Company, Endo International Plc, GlaxoSmithKline Plc, Johnson & Johnson , Merck & Co., Novartis AG, Pfizer Inc., Sanofi SA and Teva Pharmaceutical Industries Limited.

The report has segmented the market on the basis on region, treatment type, drug type, route of administration and distribution channel.

Breakup by Treatment Type:

Abortive Treatment
Preventive Treatment

Breakup by Drug Type:

Ergot Alkaloids
Acetylcholine Inhibitors/ Neurotoxins

Breakup by Route of Administration:


Breakup by Distribution Channel:

Hospital-Based Pharmacies
Retail Pharmacies

Breakup by Region:

North America: (United States, Canada)
Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America: ( Brazil, Mexico, Others)
Middle East and Africa

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure:

If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

Key highlights of the report:

Market Performance (2016-2021)
Market Outlook (2022- 2027)
Porter's Five Forces Analysis
Market Drivers and Success Factors
SWOT Analysis
Value Chain
Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Contact Us:

30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe:- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Autres actualités de la marque

inscrit avec succès

Félicitations, vous êtes inscrit sur BABBLER !

Pour découvrir dès maintenant toutes les actualités qui vous attendent sur Babbler, consultez votre newsfeed !

Vos domaines ont été préselectionnés. Vous pouvez les compléter en cliquant ici